Propanc Biopharma Inc. Company Profile
NASDAQ: PPCBHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Nov 20, 4:00 PM ET · Delayed 15 min
Propanc Biopharma at a glance
Propanc Biopharma Inc. (NASDAQ: PPCB) is a Biotechnology: Pharmaceutical Preparations company in the Health Care sector headquartered in Camberwell, VIC, Australia. Propanc Biopharma is led by Mr. James Nathanielsz and employs about 2 people. At a market capitalization of $1.8 million, it is considered a small-cap company.
Its SEC Central Index Key (CIK) is 0001517681, which identifies the company's filings on EDGAR.
Summary generated from market data by MetaCap's automated system. Methodology
What does Propanc Biopharma do?
Propanc Biopharma, Inc., a development-stage biopharmaceutical healthcare company, engages in the development of cancer treatments for patients with pancreatic, ovarian, and colorectal cancers in Australia. Its lead product candidate is PRP, an intravenous injection proenzyme treatment designed as a therapeutic option in cancer treatment and prevention which has completed pre-clinical studies. The company has a research and collaboration agreement with the University of Jaén, to undertakes the research activities for the POP1 Program and the University of Granada to develop a synthetic recombinant version of PRP. Propanc Biopharma, Inc. was formerly known as Propanc Health Group Corporation and changed its name to Propanc Biopharma, Inc. in April 2017. The company was incorporated in 2007 and is based in Camberwell, Australia.
Business description based on the company's public filings.
Company information
- Legal name
- Propanc Biopharma Inc.
- Ticker
- NASDAQ: PPCB
- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- CEO
- Mr. James Nathanielsz
- Employees
- 2
- Headquarters
- 302, 6 Butler Street, Camberwell, VIC, Australia
- Phone
- 61 3 9882 0780
- Website
- propanc.com
- Market cap
- $1.83M
- SEC CIK
- 0001517681
- Latest annual report
- 10-K · Sep 25, 2026
Companies similar to Propanc Biopharma
| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| SBFMSunshine Biopharma Inc. | 2.23 | -5.11% | $1.84M | vs PPCB |
| PPBTPurple Biotech Ltd. ADR | 1.53 | -4.09% | $1.86M | vs PPCB |
| XRTXXORTX Therapeutics Inc. | 0.839 | -5.73% | $1.88M | vs PPCB |
| EOCNEocene Ltd. | 1.78 | +1.73% | $1.90M | vs PPCB |
| KALAKALA BIO Inc. | 2.71 | -10.28% | $1.74M | vs PPCB |
| GNPXGenprex Inc. | 1.45 | -13.17% | $1.94M | vs PPCB |
| DCOYDecoy Therapeutics Inc. | 0.8294 | -4.68% | $1.98M | vs PPCB |
| REVBRevelation Biosciences Inc. | 3.50 | -5.15% | $1.99M | vs PPCB |